Legionella pneumophila actively modulates host vesicle trafficking pathways to facilitate its intracellular replication with effectors translocated by the Dot/Icm type IV secretion system (T4SS) 1 . The SidM/DrrA protein functions by locking the small GTPase Rab1 into an active form by its guanine nucleotide exchange factor (GEF) and AMPylation activity [2] [3] [4] . Here we demonstrate that the L. pneumophila protein SidD preferably deAMPylates Rab1. We found that the deAMPylation activity of SidD could suppress the toxicity of SidM to yeast and is required to release Rab1 from bacterial phagosomes efficiently. A molecular mechanism for the temporal control of Rab1 activity in different phases of L. pneumophila infection is thus established. These observations indicate that AMPylation-mediated signal transduction is a reversible process regulated by specific enzymes.
L. pneumophila, the aetiological agent of Legionnaires' disease, is capable of colonizing a wide range of eukaryotic cells. Successful infection by this pathogen requires the Dot/Icm T4SS, which translocates numerous protein substrates into host cells 1 . These proteins modulate various host cellular pathways, such as vesicle trafficking, cell death, lipid metabolism and protein synthesis, to construct a phagosome permissive for intracellular bacterial replication 5 . Accumulating evidence suggests that a unique repertoire of effectors is required for each phase of the infection. There is a need for the bacterium to regulate the activity of its virulence factor, because some effectors are potentially detrimental to host cells. Such regulation can be achieved by various mechanisms, including the control of the amount of protein delivered into host cells, the stability of the protein or susceptibility of the protein to host degradation machinery. L. pneumophila has evolved unique mechanisms to neutralize the activity of effectors whose functions presumably have become detrimental to, or no longer important for, the development of the bacterial phagosome. For example, several hours after infection, the bacterial E3 ubiquitin ligase, LubX, targets the effector SidH for proteasomal degradation 6 . Similarly, several hours after uptake, LepB, a GTPase activation protein (GAP) for Rab1, antagonizes the effects of SidM (also known as DrrA), which recruits the small GTPase to the Legionella-containing vacuole (LCV) and converts it into the active GTP-bound form via its guanine nucleotide exchange factor (GEF) activity 2, 3, 7 . SidM also catalyses an adenosine monophosphate modification (AMPylation) on the tyrosine 77 of Rab1 to lock it into the active form 4 . Post-translational modification by AMPylation has recently emerged as a novel cellular signalling mechanism used by all domains of organisms 8, 9 . However, little is known about the regulation of this signalling mechanism and naturally occurring enzymes involved in the reversal of the modification remain elusive.
In an earlier study we isolated a number of Dot/Icm substrates toxic to yeast, such as SidI, Lgts, SidM and AnkX 10-12 . To determine whether the activity of any of these proteins is under direct regulation of bacterial factors, we initiated screenings to identify L. pneumophila proteins capable of suppressing the toxicity to yeast. A plasmid-borne L. pneumophila genomic library was introduced into yeast strains expressing toxic effectors from a galactose-inducible promoter, leading to the identification of a number of clones that efficiently suppress the toxicity of SidM. Sequencing revealed that all of these clones harboured sidD (lpg2465), which encodes a Dot/Icm substrate of 507 amino acids 13 . In the L. pneumophila genome, sidD is localized next to sidM and these two genes are transcribed in divergent orientations 2, 13, 14 .
Co-expression of sidD completely rescued the growth of the SidMproducing yeast strain on inducing media ( Fig. 1a ). SidD was unable to suppress the toxicity of AnkX, which is believed to interfere with host vesicle trafficking by AMPylating substrate(s) as yet unidentified in a Fic-domain-dependent manner 15 ( Supplementary Fig. 1 ), indicating that the suppressor activity of SidD is specific for SidM.
SidM is a protein of multiple functions, which by binding to phosphatidylinositol 49-monophosphate, anchors on the Legionella vacuole, recruits and activates the small GTPase Rab1 2,3,16 . In particular, its amino-terminal domain (SidM1-339) possesses an adenosine monophosphorylation (AMPylation) activity, which covalently modifies Rab1 at tyrosine 77 in a process that requires the G 98 X (11) D 110 XD 112 motif conserved between SidM and the glutamine synthetase adenylyl transferase 4 . We thus examined whether SidD is able to suppress the toxicity induced by SidM1-339. Expression of SidM1-339 strongly inhibited yeast growth ( Fig. 1a , strain F) and such inhibition can be suppressed by SidD (Fig. 1a , strain G), indicating that SidD interferes with the activity conferred by the AMPylation function. We also examined the ability of SidD to suppress the AMPylation-dependent toxicity of SidM1-339 in mammalian 293T cells 4 . Transfection of these cells with green fluorescent protein-conjugated SidM1-339 (GFP-SidM1-339) led to extensive cell rounding. Cotransfection of the cells to express Flag-SidD suppressed this toxicity ( Fig. 1c-e ). When five times more DNA of the SidD-expressing plasmid was used, at least 85% of the cells were protected ( Fig. 1c-e ). Together, these data suggest that SidD is able to neutralize the effect of SidM in eukaryotic cells either by inhibiting its AMPylation activity or by reversing its effects on the target molecule Rab1.
To determine the mechanism of action of SidD, we tested its effect on the AMPylation activity of SidM with purified recombinant proteins. Incubation of glutathione-S-transferase-conjugated SidM (GST-SidM) with GST-Rab1 in the presence of [a-32 P]ATP for 30 min led to robust production of radiolabelled Rab1 (Fig. 2a, lane 1) . Consistent with the genetic data, inclusion of His 6 -SidD in the AMPylation reaction abolished the formation of [a-32 P]AMP-Rab1 (Fig. 2a, lane 2) . The lack of AMPylation can be a result of SidD-mediated inhibition of SidM activity or of a deAMPylation function of SidD. Because full-length SidM has a high binding affinity for Rab1 (refs 2-4), its presence may interfere with SidD activity. We distinguished between these two possibilities by producing [a-32 P]AMP-Rab1 using His 6 -SidM1-339, which catalyses the reaction but did not detectably bind GST-Rab1 in vitro 2-4 (Supplementary Fig. 2 ). After removing His 6 -SidM1-339, AMPylated Rab1 was incubated with various amounts of His 6 -SidD for 5 min. Under these conditions, the amount of radiolabelled GST-Rab1 significantly decreased when as little as 0.6 mg His 6 -SidD was included in the reaction, and 1.2 mg His 6 -SidD can almost completely deAMPylate [a-32 P]AMP-Rab1 (Fig. 2b) . In a time course analysis, incubation of 1.0 mg SidD with 10 mg modified Rab1 for 1 min led to more than a 50% reduction in radiolabelled substrate ( Fig. 2c ). SidD is also able to remove the AMP moiety from other Rab proteins modified by SidM 4 (Supplementary Fig. 3 ).
To verify the SidD-mediated removal of the AMP moiety from modified Rab1, AMPylated Rab1 treated with His 6 -SidD completely digested with trypsin was subjected to mass spectrometric analysis. The relative intensity ratio data showed that approximately 50% of the Rab1 was AMPylated when 10 mg Rab1 was incubated with 1.5 mg SidM for 30 min ( Supplementary Fig. 4a ). The ratio of unmodified Rab1 increased about tenfold when 4 mg His 6 -SidD was added to the reaction for 10 min and further increased to 20-fold when the incubation was extended for 30 min ( Supplementary Fig. 4b, c ). Furthermore, we did not detect any mass loss of the Rab1 peptide containing tyrosine 77, indicating that deAMPylation by SidD was not caused by other hydrolytic reaction. Taken together, these results indicate that SidD is a deAMPylase that functions to reverse the SidM-mediated post-translational modification of Rab1.
Sequence analysis with HHPred 17 revealed that the predicted secondary structure of SidD N-terminal portion is detectably similar to some protein phosphatases ( Supplementary Fig. 5 ). In particular, the Asp residues at positions 92 and 110 of SidD are conserved with residues critical for the biochemical activity of SaSTP and tPphA, phosphatases from Streptococcus agalactiae and Thermosynechococcus elongates, respectively 18, 19 (Supplementary Fig. 5 ). Substitution of D92 or D110 with alanine completely abolished the ability of SidD to suppress the toxicity of SidM to yeast, whereas a mutation in D60 did not detectably affect its activity (Fig. 3a, b) . Consistently, SidD D92A and SidD D110A both had lost the activity to remove the AMP moiety from AMPylated Rab1 (Fig. 3c) . These results indicate that residues D92 and D110 participate in the formation of the catalytic pocket or structural features important for its enzymatic function.
In bone-marrow-derived mouse macrophages, the association of Rab1 with LCVs peaks at 2 h after bacterial uptake and begins to 
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disappear when infection has proceeded for 4 h (ref. 7) . The removal of Rab1 from LCVs is presumably due to extraction by RabGDI, which only interacts with the inactive GDP-bound form 20 . LepB is unable to induce GTP hydrolysis of AMPylated Rab1, suggesting that a deAMPylation factor is necessary for the production of the GDPbound, inactive Rab1 (ref. 4). Thus, we examined whether SidD is required for efficient removal of Rab1 from the LCVs. In infections with wild-type bacteria, the percentages of vacuoles staining positively for Rab1 began to diminish at 2 h (Fig. 4a ). On the other hand, in infections with the sidD deletion mutant, the rates of Rab1-positive vacuoles remained at the maximal level (about 60%) 4 h after infection (Fig. 4) . The kinetics of Rab1-positive LCVs was restored to the pattern of wild-type bacteria when SidD was expressed in the mutant (Fig. 4a,  b) . Interestingly, the association of Rab1 with the LCV did not persist after 4 h of infection with the sidD mutant ( Fig. 4a ), suggesting the contribution of host deAMPylases or additional bacterial proteins for reversal of the modification. These results indicate that SidD plays an important role in the efficient removal of Rab1 from the Legionella phagosome.
AMPylation of proteins often leads to alteration of their enzymatic activity or the ability to interact with target molecules 4, 8, 21, 22 . Proteins with AMPylation activity dependent upon the Fic domain are present in all kingdoms and at least one has been characterized in humans 8,9 . Although the importance of signalling pathways regulated by AMPylation has not yet been fully recognized, the fact that this reaction can be catalysed by proteins lacking a Fic domain such as SidM suggests extensive involvement of this post-translational modification in cellular signalling processes. The identification of a deAMPylase revealed that like other post-translational modifications involved in signal transduction, AMPylation is a reversible process regulated by specific enzymes. Similar to sidM 2,3 and lepB 7 , sidD is not required for bacterial intracellular growth 13 , probably because of functional redundancy among the several hundred Dot/Icm substrates 23 or because of the limitation of the experimental systems. Nevertheless, further study on the structure and function of SidD will advance not only our understanding of its roles in bacterial pathogenesis but also the involvement of such enzymes in other cellular processes.
METHODS SUMMARY
Bacterial, yeast strains and plasmid construction. All L. pneumophila strains used in this study were derivatives of the Philadelphia 1 strain Lp02 (ref. 24) . Escherichia coli strains were grown and maintained on LB agar or LB broth. When necessary antibiotics were included as described 25 . Strains of L. pneumophila were grown and maintained on CYE medium or in AYE broth as previously described 25 . The sidD in-frame deletion mutant was constructed in an earlier study 13 . In this mutant, the open reading frame of sidD was replaced by a 32amino-acid polypeptide consisting of the first and the last 15 amino acids and two amino acids encoded by the sequence of the BamHI restriction enzyme 13 . For complementation experiments, a Flag-tagged sidD gene was inserted into the sidD locus of the deletion mutant using a two-step site-specific recombination with the p-protein-dependent plasmid pSR47s 24 with an established procedure 26 
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as increase of bacterial motility. For expression in mammalian cells, genes were cloned into pEGFPC1 (Clontech) or a 43Flag vector (Sigma). The integrity of all constructs was verified by sequencing analysis. The sequences of all primers used in this study are listed in Supplementary Table 1 .
All yeast strains used were derived from W303 (ref. 27); yeast was grown at 30 uC in YPD medium or in appropriate amino acid dropout synthetic media with glucose or galactose at a final concentration of 2% as the sole carbon source. Yeast transformation was performed according to a standard procedure 28 .
